117 related articles for article (PubMed ID: 9733049)
1. Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?
Lassen UN; Hirsch FR; Osterlind K; Bergman B; Dombernowsky P
Lung Cancer; 1998 Jun; 20(3):151-60. PubMed ID: 9733049
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel added to the cisplatin/etoposide regimen in extensive-stage small cell lung cancer -- the use of complete response rate as the primary endpoint in phase II trials.
Dowlati A; Crosby L; Remick SC; Makkar V; Levitan N
Lung Cancer; 2001 May; 32(2):155-62. PubMed ID: 11325486
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute.
Chute JP; Venzon DJ; Hankins L; Okunieff P; Frame JN; Ihde DC; Johnson BE
Mayo Clin Proc; 1997 Oct; 72(10):901-12. PubMed ID: 9379691
[TBL] [Abstract][Full Text] [Related]
5. The impact of dose intensity of standard chemotherapy regimens in extensive stage small cell lung cancer.
Sheehan RG; Balaban EP; Frenkel EP
Am J Clin Oncol; 1993 Jun; 16(3):250-5. PubMed ID: 8393273
[TBL] [Abstract][Full Text] [Related]
6. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
Jett JR; Hatfield AK; Hillman S; Bauman MD; Mailliard JA; Kugler JW; Morton RF; Marks RS; Levitt R
Cancer; 2003 May; 97(10):2498-503. PubMed ID: 12733149
[TBL] [Abstract][Full Text] [Related]
7. Treatment of small cell lung cancer in the elderly.
Shepherd FA; Amdemichael E; Evans WK; Chalvardjian P; Hogg-Johnson S; Coates R; Paul K
J Am Geriatr Soc; 1994 Jan; 42(1):64-70. PubMed ID: 8277118
[TBL] [Abstract][Full Text] [Related]
8. [Early irradiation with radiochemotherapy for limited-stage small cell lung cancer is superior to late irradiation].
Fietkau R; Sauer R
Strahlenther Onkol; 2002 Nov; 178(11):585-8. PubMed ID: 12518770
[No Abstract] [Full Text] [Related]
9. Chemotherapy versus best supportive care for extensive small cell lung cancer.
Agra Y; Pelayo M; Sacristan M; Sacristán A; Serra C; Bonfill X
Cochrane Database Syst Rev; 2003; (4):CD001990. PubMed ID: 14583943
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of weekly alternating chemotherapy in extensive-stage small cell lung cancer.
Kalemkerian GP; Ali MA; Luthra K; Wozniak AJ; Valdivieso M; Kraut MJ
Cancer Invest; 2001; 19(3):234-8. PubMed ID: 11338879
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancer.
Garst J; Herndon JE; Shafman T; Campagna L; Blackwell S; Padilla K; Bjurstrom T; Andrews C; Maravich-May D; Anderson E; Crawford J
Clin Drug Investig; 2006; 26(5):257-66. PubMed ID: 17163259
[TBL] [Abstract][Full Text] [Related]
12. [Recent progress in chemotherapy for advanced lung cancer].
Negoro S; Fukuoka M
Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of two different platinum- or anthracycline-containing chemotherapy regimens for the treatment of small cell lung cancer.
Tassinari D; Genestreti G; Pasquini E; Papi M; Fantini M; Tamburini E; Fochessati F; Poggi B; Imola M; Mianulli AM; Fattori PP; Lazzari-Agli L; Ioli G; Sartori S; Ravaioli A
J Chemother; 2005 Apr; 17(2):228-36. PubMed ID: 15920911
[TBL] [Abstract][Full Text] [Related]
14. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
[TBL] [Abstract][Full Text] [Related]
15. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
16. Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.
Miller AA; Herndon JE; Hollis DR; Ellerton J; Langleben A; Richards F; Green MR
J Clin Oncol; 1995 Aug; 13(8):1871-9. PubMed ID: 7636529
[TBL] [Abstract][Full Text] [Related]
17. Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study.
Ettinger DS; Finkelstein DM; Abeloff MD; Skeel RT; Stott PB; Frontiera MS; Bonomi PD
J Natl Cancer Inst; 1992 Jul; 84(14):1077-84. PubMed ID: 1320131
[TBL] [Abstract][Full Text] [Related]
18. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
19. Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial.
Tiseo M; Boni L; Ambrosio F; Camerini A; Vitale MG; Baldini E; Cinieri S; Zanelli F; Defraia E; Passalacqua R; Crino L; Dazzi C; Tibaldi C; Turolla GM; D'Alessandro V; Zilembo N; Riccardi F; Ardizzoni A;
Clin Lung Cancer; 2015 Jan; 16(1):67-70. PubMed ID: 25450879
[TBL] [Abstract][Full Text] [Related]
20. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
Bozcuk H; Artac M; Ozdogan M; Savas B
Cancer; 2005 Dec; 104(12):2650-7. PubMed ID: 16284984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
